J. Byron

Persistence on Therapy and Propensity Matched Outcome Comparison of Two Subcutaneous Interferon Beta 1a Dosages for Multiple Sclerosis

J. Lechner-Scott, M. Slee, J. Correale, 2013, PloS one.

Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort

P. Nash, J. Byron, P. Hissaria, 2011, Arthritis research & therapy.

N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study

D. Liew, D. Celermajer, P. Nash, 2012, Arthritis Research & Therapy.

Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease.

N. Goh, T. Corte, P. Nash, 2013, Rheumatology.